<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00315913</url>
  </required_header>
  <id_info>
    <org_study_id>HS #2004-3997</org_study_id>
    <nct_id>NCT00315913</nct_id>
  </id_info>
  <brief_title>Trial of Oxytocin Alone Versus Oxytocin and Propranolol for the Treatment of Abnormal Labor</brief_title>
  <official_title>Placebo-Controlled Randomized Trial of Oxytocin Alone Versus Oxytocin and Propranolol for the Treatment of Dysfunctional Labor</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Irvine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, Irvine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether propranolol is better than oxytocin for the
      treatment of labor abnormalities. The endpoint is the rate of vaginal delivery experienced by
      women receiving prolonged oxytocin versus propranolol.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This trial was designed to test if propranolo can reduce the c section rate for dysfuctional
      labor. Due to stringent inclution and exclusion criteria and low enrollment the study was
      closed.
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Lack of feasibility
  </why_stopped>
  <start_date>January 2004</start_date>
  <completion_date type="Actual">March 2008</completion_date>
  <primary_completion_date type="Actual">March 2008</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Dysfunctional Labor</condition>
  <arm_group>
    <arm_group_label>IV Propranolol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>IV dose propranolol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IV Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>IV Placebo of saline solution equal to propranolol in volume</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propranolol</intervention_name>
    <description>IV Propranolol 1mg/min for a total of 2 minutes. Total dose 2mg</description>
    <arm_group_label>IV Propranolol</arm_group_label>
    <other_name>Inderal</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>IV Placebo</intervention_name>
    <description>IV Saline Solution</description>
    <arm_group_label>IV Placebo</arm_group_label>
    <other_name>Normal Saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Must be term pregnancy (&gt; 37 weeks)

          -  Vertex presentation

          -  Active labor (4-5 centimeters dilated)

        Exclusion Criteria:

          -  Heart disease

          -  Diabetes

          -  Currently taking propranolol

          -  Contraindications to labor or vaginal delivery

          -  Multiple gestations

          -  Preterm

          -  Chorioamnionitis
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Leah R Battista, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Irvine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Long Beach Memorial Medical Center</name>
      <address>
        <city>Long Beach</city>
        <state>California</state>
        <zip>90806</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>April 17, 2006</study_first_submitted>
  <study_first_submitted_qc>April 17, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 19, 2006</study_first_posted>
  <last_update_submitted>February 26, 2019</last_update_submitted>
  <last_update_submitted_qc>February 26, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">February 27, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, Irvine</investigator_affiliation>
    <investigator_full_name>Deborah A. Wing</investigator_full_name>
    <investigator_title>Professor and MFM Division Director</investigator_title>
  </responsible_party>
  <keyword>Labor</keyword>
  <keyword>Dysfunctional Labor</keyword>
  <keyword>Labor Arrest</keyword>
  <keyword>Primary Cesarean Section Prevention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dystocia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propranolol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

